16.1 Failure to Thrive, Undernutrition & Pediatric Obesity
Key Takeaways
- Failure to thrive is a growth pattern (crossing two major weight percentiles, weight <5th, or weight-for-length <2nd), not a single lab — history of calories, feeding, social context, vomiting, and stool comes before a shotgun panel.
- Plot WHO charts from birth to 2 years and CDC BMI-for-age from 2 years; mixed psychosocial-plus-medical contributors are more common than a pure organic versus nonorganic split.
- Obesity is BMI-for-age ≥95th percentile; overweight is 85th to <95th. The 2023 AAP obesity guideline treats obesity as a chronic disease: start intensive health behavior and lifestyle treatment — do not watch and wait.
- Screen obesity comorbidities (lipids, A1c/glucose, NAFLD/ALT, hypertension, OSA, PCOS) and use motivational interviewing; pharmacotherapy and metabolic/bariatric surgery are adjunct specialty pathways, not the opening move of the first visit.
- Vitamin D (400 IU daily in infancy) and iron deficiency are primary-care nutrition diagnoses; weight talk never uses shame, blame, or “just eat less.”
Nutrition is clinical category #9 on the CPNP-PC outline. Items sit in Assessment (Domain II) and Management (Domain III) and follow AAP/CDC growth rules plus the 2023 AAP Clinical Practice Guideline on pediatric obesity. The scoring skill is naming the right energy problem: not enough in, not enough absorbed, too much expenditure, or energy stored as disease-level adiposity — then acting without a fishing-expedition laboratory panel or a shame lecture.
Quick Answer: Failure to thrive is a trajectory, not one percentile. Take a calorie, feeding, social, vomiting, and stool history, plot WHO (0–2 years) or CDC BMI-for-age (≥2 years), and order targeted tests. Obesity is BMI ≥95th; overweight is 85th–<95th. Do not watch and wait. Start intensive health behavior and lifestyle treatment (IHBLT), screen comorbidities, use motivational interviewing, and treat vitamin D and iron deficiency. Pharmacotherapy and surgery are adjunct specialty pathways, not the first sentence of the first visit.
Failure to thrive is a pattern
Failure to thrive (FTT) — also called growth faltering or undernutrition — is inadequate weight gain or weight loss relative to expected growth. Common operational criteria, none of them a single universal AAP number, include crossing two or more major weight percentile lines downward, weight below the 5th percentile, and weight-for-length below the 2nd percentile on WHO charts (or BMI <5th after age 2). Confirm the measurement before you name the disease: wrong chart, uncorrected prematurity, clothes on the scale, and a length-to-height switch at 24 months all fake FTT. Chapter 6 is the plotting skill; this section is the workup and nutrition plan.
Weight usually falls first, then length/height, then head circumference. If head circumference falls first or fastest, think neurologic, genetic, or craniosynostosis — not “the baby is a picky eater.” A child who has always tracked the 10th percentile with short parents and normal velocity is not FTT.
History before laboratories
The FTT interview is the test. Ask what actually went into the child, how it went in, what came back out, and who is feeding whom.
| History domain | What you must extract | Why it changes the plan |
|---|---|---|
| Calories | Formula mixing (packed scoops versus extra water), volumes, breastfeeding frequency and transfer, juice, grazing, toddler milk, sports drinks | Dilute formula and juice displacement are common, reversible energy deficits |
| Feeding mechanics | Nipple flow, oral-motor dysfunction, coughing/choking, timed meals versus all-day bottle, texture progression | Oromotor or cardiorespiratory limits are not “behavioral” until you look |
| Social | Food insecurity, caregiver mental health, chaotic schedules, unusual beliefs, possible neglect | Nonorganic intake failure is a safety diagnosis as well as a nutrition one |
| Vomiting | Force, bile, blood, relation to feeds | GERD, pyloric stenosis, obstruction, increased ICP |
| Stool | Frequency, blood, mucus, oily stool, delayed meconium | CMPA, celiac, pancreatic insufficiency, Hirschsprung |
Watch a feed when you can. A 20-minute history of “he eats fine” collapses when you see 2 ounces over 40 minutes with coughing. Review WIC, SNAP, and who buys groceries. Food insecurity is a vital sign in FTT; a metabolic panel does not replace a pantry history.
Mixed, organic, and “nonorganic”
Older stems still say organic (medical disease: malabsorption, congenital heart disease, renal disease, thyroid, malignancy, inborn error) versus nonorganic (inadequate intake from psychosocial or feeding problems). Real children are usually mixed: a medically complex infant who also has an exhausted caregiver, or a toddler with celiac whose family cannot afford gluten-free food. Do not stop at a social label if diarrhea, steatorrhea, recurrent infection, dysmorphology, or developmental delay is sitting in the room. Do not order a chromosomal microarray as the first move in an otherwise well infant whose formula is mixed with extra water.
Inadequate intake, inadequate absorption, and increased metabolic demand (heart failure, hyperthyroidism, chronic inflammation, malignancy) are the three physiologic buckets. Match the bucket to the story, then test that hypothesis.
Targeted labs, not a shotgun
There is no mandatory 20-test FTT panel. After history, exam, and correct plotting, targeted studies might include CBC (iron deficiency, inflammation, marrow), lead when indicated, urinalysis (renal loss, UTI), and — when the story supports them — tTG-IgA with total IgA, TSH, or a chemistry panel. Sweat chloride, fecal elastase, karyotype, and inborn-error panels belong to specific clues (salty skin and recurrent pneumonia, oily stools, dysmorphology, unexplained hypoglycemia or hepatomegaly), not to every child below the 10th percentile. The CPNP-PC trap is laboratories instead of a feeding history, or chromosomes first when the child looks nutritionally starved and socially stressed without syndromic features.
Nutrition rehabilitation is food, not a multivitamin as monotherapy. Fix mixing errors, concentrate feeds with specialty guidance when needed, schedule meals, limit juice, treat constipation that makes eating painful, and involve social work and WIC. Refer pediatric GI, nutrition, or child-protection pathways when red flags or failed primary-care rehabilitation demand it. Hospitalize for severe malnutrition, dehydration, hypothermia, bradycardia, or unsafe home intake.
Pediatric obesity is a chronic disease (AAP 2023)
From age 2 years, use CDC BMI-for-age.
| BMI-for-age | Category |
|---|---|
| 5th to <85th | Healthy weight |
| 85th to <95th | Overweight |
| ≥95th | Obesity |
| ≥120% of the 95th percentile | Severe (class 2) obesity in AAP 2023 language |
Do not apply adult BMI 30 kg/m² to a school-age child. Do not diagnose obesity from weight-for-age in a tall athlete.
The 2023 AAP Clinical Practice Guideline retired watchful waiting as the sole plan. Obesity is a chronic disease with genetics, environment, and SDoH — not a willpower failure. At the visit you diagnose it, you evaluate it, and you treat it.
Intensive health behavior and lifestyle treatment (IHBLT) is the foundation: family-based, multicomponent nutrition, activity, and behavior support. The evidence-based intensity is ≥26 hours of face-to-face contact over 3–12 months. A one-time “eat more vegetables” handout is not IHBLT. If a comprehensive program is not in the parking lot, still start structured family goals, follow frequently, and build toward intensity — do not postpone all care until a perfect tertiary clinic exists.
Motivational interviewing (open questions, reflective listening, collaborative agenda) outperforms lectures. Ask what the family is ready to change. Celebrate non-scale wins (endurance, fasting glucose, sleep, soda-free days).
Do not shame. Stigma worsens outcomes and disordered eating. Weigh privately, use people-first language (“child with obesity,” not “obese kid”), never joke about body size, and never bargain food as morality. Caregivers who were shamed as children need a different script, not a repeat of it.
Comorbidities and specialty pathways
Evaluate lipids, glucose/A1c, NAFLD (ALT), hypertension, OSA symptoms (snoring, pauses, daytime sleepiness, enuresis), and PCOS (oligomenorrhea, hirsutism, acanthosis) according to age and BMI category. AAP key action statements push lipid, glucose, and liver evaluation in children 10 and older with obesity, and lipids in those 10 and older with overweight; younger children still get a history, BP, and risk-based labs. Acanthosis nigricans is insulin-resistance theater, not dirt — do not scrub it, document it, and screen for T2D risk.
Pharmacotherapy (AAP: offer as an adjunct to IHBLT for adolescents ≥12 years with obesity, with attention to FDA labeling) and metabolic/bariatric surgery (offer evaluation for adolescents ≥13 years with severe obesity at a comprehensive pediatric surgical center) are real options. They are not the first clinic visit’s only intervention, and they are not first-line for an 86th-percentile child. Primary care starts diagnosis, comorbidity screening, MI, and IHBLT, then refers into obesity-medicine, endocrine, or surgical pathways when criteria are met. Do not withhold discussion of those pathways out of misplaced “they should just try harder,” and do not open the visit with a GLP-1 or an OR date before you have named the disease and the behavior plan.
Vitamin D and iron
Vitamin D 400 IU daily starts in the first days of life for all infants (AAP). Exclusive breastfeeding without a supplement is a rickets setup, especially with dark skin, limited sun, or fat-malabsorption. After infancy, 600 IU daily is the usual dietary-reference intake. At-risk children get a 25-OH vitamin D level; universal screening of every well child is not the point — missing the exclusively breastfed infant who never got drops is. Rickets: delayed fontanelle, wrist widening, rachitic rosary, bowing, high ALP, low/low-normal calcium and phosphorus, high PTH, low 25-OH D.
Iron deficiency is the most common nutritional deficiency you will treat. Risk: prematurity, delayed/insufficient iron complementary foods, cow’s milk before 12 months, excessive cow’s milk (often >16–24 oz/day) in toddlers, restricted diets. Bright Futures hemoglobin screening at 12 months is a disease-screening tool, not a nutrition history substitute. Microcytic anemia, high RDW, and low ferritin support iron deficiency; treat with elemental iron (commonly 3–6 mg/kg/day) plus dietary change, and stop the milk flood. Recheck to confirm response. Do not call every low hemoglobin “thalassemia” without a trial and indices, and do not give iron “just in case” forever without a diagnosis.
Exam traps
- Watch-and-wait obesity. The 2023 AAP guideline treats now.
- Shotgun FTT labs with no feeding or social history.
- CDC infant charts or BMI before age 2 (that is Chapter 6’s trap reused here as a wrong workup trigger).
- Shame as counseling.
- Surgery or pharmacotherapy as the first and only sentence of visit one — or, the opposite error, never referring an eligible adolescent.
- Skipping vitamin D in a breastfed newborn and skipping iron in a toddler living on milk.
Name the energy problem, plot it, ask what is eaten and by whom, test with a hypothesis, treat obesity as chronic disease, and keep the child’s dignity intact.
A 10-year-old has a BMI at the 97th percentile. Blood pressure is elevated in clinic, and the caregiver asks to “wait a year and see if he grows into his weight.” Which plan matches the 2023 AAP obesity guideline?
A 9-month-old has crossed two major weight percentiles downward. Formula is mixed with extra water, stools are normal, and the exam is nondysmorphic. What is the best next diagnostic approach?
A 9-year-old has a BMI at the 92nd percentile, no acanthosis, and a family that feels blamed after a prior “just eat less” visit. Which interpretation is correct?